SCHEMBL8304591

SCHEMBL8304591

C/C(=N/OCCO)c1ccc2ccccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.58
PPARA Q07869 3/20 0.58
MAPT P10636 3/20 0.45
LMNA P02545 3/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
ALOX12 P18054 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
CASP3 P42574 1/20 0.41
GFER P55789 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8304592 1.00 PPARG (0.58) PPARGPPARAMAPTLMNAMAPK1
SCHEMBL4476864 0.80 LMNA (0.69) PPARGPPARAMAPTLMNAMAPK1
SCHEMBL4476867 0.80 LMNA (0.69) PPARGPPARAMAPTLMNAMAPK1
SCHEMBL9633241 0.78 PPARG (0.48) PPARGPPARAMAPTLMNAALDH1A1
SCHEMBL5610797 0.78 LMNA (0.56) PPARGPPARAMAPTLMNAMAPK1
SCHEMBL5610798 0.78 LMNA (0.56) PPARGPPARAMAPTLMNAMAPK1
SCHEMBL8308303 0.77 PPARA (0.62) PPARGPPARALMNAMAPK1HTT
SCHEMBL8308305 0.77 PPARA (0.62) PPARGPPARALMNAMAPK1HTT
SCHEMBL17577932 0.75 PPARA (0.51) PPARGPPARAMAPTLMNAMAPK1
SCHEMBL11963960 0.74 CES2 (0.52) PPARGPPARAMAPTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed